Claudine Wack

A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma

Thomas G. Martin, Rachid Baz, Don M. Benson et al. · Blood · 2017 · 166 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

Plateable cryopreserved human hepatocytes for the assessment of cytochrome P450 inducibility: experimental condition-related variables affecting their response to inducers

Eliane Alexandre, Audrey Baze, C. Parmentier et al. · Xenobiotica · 2012 · 37 citations

Medicine, Biochemistry, Pharmacology +16

Preliminary Results from a Phase Ib Study of Isatuximab in Combination with Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma

Paul G. Richardson, Joseph Mıkhael, Saad Z. Usmani et al. · Blood · 2016 · 23 citations

Medicine, Oncology, Pharmacotherapy +16

Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid.

A. H. Staib, S. Harder, Uwe Fuhr et al. · PubMed · 1989 · 21 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +10

Preliminary Results From a Phase Ib Study of Isatuximab in Combination with Pomalidomide (Pom) and Dexamethasone (Dex) in Relapsed and Refractory Multiple Myeloma (RRMM)

Paul Richardson, Joseph Mıkhael, Saad Z. Usmani et al. · Clinical Lymphoma Myeloma & Leukemia · 2017 · 21 citations

Medicine, Hematology, Pharmacotherapy +15